301080.SZ
百普赛斯
SZSE · M 科研服务 · CN
CNY 92.63
−6.36%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 887.2M | 838.1M | 645.0M | 543.7M | 474.4M |
| Cost of Revenue | 78.9M | 74.1M | 58.5M | 47.5M | 35.5M |
| Gross Profit | 808.3M | 764.0M | 586.5M | 496.2M | 438.9M |
| Operating Expenses | |||||
| R&D Expense | 186.9M | 184.2M | 165.3M | 124.9M | 113.9M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 146.6M | 138.9M | 110.7M | 84.3M | 71.5M |
| Selling & Marketing Expense | 261.5M | 248.9M | 207.1M | 167.6M | 112.4M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 569.6M | 541.4M | 426.0M | 316.7M | 245.1M |
| Cost and Expenses | 648.5M | 615.5M | 484.5M | 364.2M | 280.6M |
| Operating Income (EBIT) | 175.8M | 169.8M | 125.4M | 161.1M | 216.5M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 175.3M | 169.3M | 124.9M | 160.7M | 215.0M |
| Income Tax Expense | 4.5M | 4.5M | 4.9M | 13.1M | 15.8M |
| Bottom Line | |||||
| Net Income | 171.2M | 165.6M | 123.8M | 153.6M | 203.7M |
| Earnings from Cont. Ops | 170.8M | 164.8M | 120.0M | 147.6M | 199.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 171.2M | 165.6M | 123.8M | 153.6M | 203.7M |
| Per Share | |||||
| Basic EPS | CN¥1.02 | CN¥0.99 | CN¥0.74 | CN¥1.28 | CN¥1.70 |
| Diluted EPS | CN¥1.02 | CN¥0.99 | CN¥0.74 | CN¥1.28 | CN¥1.70 |
| Revenue Per Share | CN¥5.31 | CN¥5.01 | CN¥3.84 | CN¥4.53 | CN¥3.95 |
| Shares | |||||
| Basic Shares Outstanding | 167.2M | 167.4M | 167.8M | 120.0M | 120.0M |
| Diluted Shares Outstanding | 167.2M | 167.4M | 167.8M | 120.0M | 120.0M |
| Profitability Metrics | |||||
| EBITDA | — | 236.1M | 175.5M | 200.1M | 241.7M |
| D&A | — | 66.3M | 50.1M | 39.1M | 25.2M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026